Gafni discusses the primary results of the phase 3 CALIBRATE trial, testing the investigational oral calcilytic in this difficult-to-treat disease state.
Rachel Gafni, MD
Advertisement
Rachel Gafni, MD, is a senior research physician at the National Institutes of Health.
Articles by Rachel Gafni, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Structuring Obesity Trials to Optimize Patient Retention and Data Integrity
2
Health Insurance Largely Controls Financial Toxicity in Patients With T1D
3
Sotatercept, De-escalation, and Systemic Barriers: A PAH Expert Forum
4
Addressing Safety Concerns with Biologic Therapies in IBD
5